3rdPartyFeeds News

The Wall Street Journal: J&J COVID vaccine shows promising signs of protecting against delta variant

Johnson & Johnson’s COVID-19 vaccine showed promising signs in a small laboratory study of protecting against the Delta variant spreading across the U.S. and other countries, the company said. Read More...

Johnson & Johnson’s COVID-19 vaccine showed promising signs in a small laboratory study of protecting against the Delta variant spreading across the U.S. and other countries, the company said.

In laboratory testing, the vaccine triggered strong levels of neutralizing antibodies in blood samples taken from eight vaccinated people, J&J JNJ, +0.74% said Thursday.

Read More

Add Comment

Click here to post a comment